Boehringer Ingelheim Middle East & NorthAfrica (Scientific Office) FZ LLC,
Index Tower –Level 15
Dubai International Financial Center(DIFC),
Dubai, United Arab Emirates, P.O. Box 507066

For any adverse events please contact Boehringer Ingelheim’s responsible Pharmacovigilance unit use the below contact details.

Mobile: +97155 9865722
Email Address: PV_local_ROPU_MENA@boehringer-ingelheim.com